Tag: Covid19 Vaccine

France-Ambassador
India will have to play key role in mass production of coronavirus vaccine: France

New Delhi: India will have an important role to play in the mass production of medicines and vaccines for coronavirus infection once the treatment for the deadly disease is found, French Ambassador Emmanuel Lenain has said. Dozens of researchers across the globe are racing against time to come out with a vaccine for coronavirus that […]

  • Friday, 16 April 2021
Coronavirus-Vaccine
COVID-19 Vaccine Likely In 2020, But Production Only By 2021 End

New Delhi: Swedens chief epidemiologist Dr Anders Tegnell said Covid-19 vaccine may be developed in 2020, but its production will only start by the end of 2021. In a webinar organized by Public Health Foundation of India, Tegnell, who is also the architect of Covid-19 Sweden’s lockdown-lite, said: “To reach full herd immunity to stop […]

  • Friday, 16 April 2021
Dexamethasone-Steroid-Drug
COVID-19 Cure Breakthrough? Dexamethasone 'Lowers' Death Risk Among Severe Patients

London: Low doses of the steroid dexamethasone can reduce deaths by one-third in severely affected COVID-19 patients, according to researchers who assessed the performance of the inexpensive drug in more than 2,100 people. The analysis is part of the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial which was established to test a range of potential […]

  • Thursday, 15 April 2021
Dexamethasone Steroid Drug
Dexamethasone Steroid Drug Approved As COVID-19 Treatment In UK

London: The UK government on Wednesday authorised the state-funded National Health Service (NHS) to use steroid dexamethasone, the world’s first coronavirus treatment proven to reduce the risk of death among severely ill patients. The Department of Health said the cheap and widely available anti-inflammatory steroid has been immediately approved to treat all hospitalised COVID-19 patients […]

  • Thursday, 15 April 2021
WHO
COVID-19 Vaccine Could Come Within 1 Year: WHO Chief

Brussels: Scientists predict the world may have a Covid-19 vaccine within one year or even a few months earlier, said the Director-General of the World Health Organisation even as he underlined the importance of global cooperation to develop, manufacture and distribute vaccines. However, making the vaccine available and distributing it to all will be a […]

  • Thursday, 15 April 2021
COVID19-Vaccine
Oxford Covid-19 Vaccine Produces Immune Response In Early Trial

London: The Covid-19 vaccine developed by scientists at the Oxford University produces strong immune responses in both parts of the immune system, showed results of the Phase I/II trial published in The Lancet medical journal on Monday. The vaccine provoked a T cell response within 14 days of vaccination — white blood cells that can […]

  • Wednesday, 14 April 2021
Moderna COVID19 Vaccine Efficacy Marginally Drops To 90% In US Trial
Moderna COVID19 Vaccine Efficacy Marginally Drops To 90% In US Trial

New York: Updated results from an ongoing Phase 3 clinical trial in the US have shown Moderna’s Covid-19 vaccine to be 90 per cent effective against all cases of the…

  • Wednesday, 14 April 2021
Favipiravir
Cipla Gets DCGI Nod To Sell Favipiravir Under Brand 'Ciplenza'

Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza to treat mild to moderate Covid-19 patients. Favipiravir is an off-patent, oral antiviral drug that has been shown to hasten clinical recovery […]

  • Wednesday, 14 April 2021
FluGuard
COVID-19: Sun Pharmaceutical Launches Favipiravir As FluGuard At Rs 35

New Delhi: Sun Pharmaceutical Industries Ltd on Tuesday announced the launch of Favipiravir, under brand name FluGuard, at Rs 35 per tablet for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is an oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease. […]

  • Wednesday, 14 April 2021
COVID-Vaccine
COVID-19 Vaccine To Cost Rs 225 Each, Serum Institute To Produce 100 Mn Doses

New Delhi: Serum Institute of India (SII), the worlds largest vaccine manufacturer by volume, has entered into a new landmark partnership with Gavi, The Vaccine Alliance and the Bill & Melinda Gates Foundation, to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for India and low- and middle-income countries […]

  • Wednesday, 14 April 2021
COVID19 Vaccine Shots Can Be Taken During Ramzan, Say Islamic Scholars
COVID19 Vaccine Shots Can Be Taken During Ramzan, Say Islamic Scholars

Srinagar/Lucknow: Taking the COVID-19 vaccine does not invalidate the Ramzan fast, Muslim scholars said on Tuesday, appealing to people not to stop taking the shots during the ‘roza’ period. A…

  • Tuesday, 13 April 2021
COVID19-Vaccine-Russia
COVID-19 Vaccine: Russia's Top Doctor Quits Over Vaccine Registration

Moscow: A top respiratory doctor quit the Russian health ministry’s ethics council after the country decided to go ahead with the registration of a Covid-19 vaccine even before conducting a crucial Phase 3 trial, MailOnline reported. It appears that Professor Alexander Chuchalin wanted to block the registration of the vaccine on “safety” grounds, before quitting […]

  • Tuesday, 13 April 2021
COVID19-Vaccine-Human-Trial
COVID-19 Vaccine Candidate To Enter 3rd Phase Human Trial, Informs Health Ministry

New Delhi: The Ministry of Health and Family Welfare informed on Tuesday that one of the three COVID-19 vaccine candidates would enter the third phase of the pre-clinical human trial by Wednesday. Dr V.K. Paul, head of the national task force on COVID-19 informed about the development during a weekly press briefing. The ministry officials […]

  • Tuesday, 13 April 2021
Anti-Fibrotic Drugs
COVID-19: Anti-Fibrotic Drugs Effective On Patients, Says Army

Mumbai: For the first time in the country, anti-fibrotic drugs have been used to treat patients suffering from COVID-19-related lung fibrosis and breathlessness which has helped in the recovery of four such patients in Maharashtra’s Pune, the Army has said. “The researchers at the Pune-based Army Institute of Cardiothoracic Sciences (AICTS) have found this therapy […]

  • Tuesday, 13 April 2021
COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax
COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax

Hyderabad: The stage is set for phase II clinical trials of Bharat Biotech’s coronavirus vaccine from Monday. The Hyderabad-based vaccine maker received the approval from Central Drugs Standard Control Organisation under the Directorate General of Health Services to conduct the phase II trials of indigenous vaccine candidate Covaxin. Joint Drugs Controller Dr S. Eswara Reddy […]

  • Monday, 12 April 2021
scrollToTop